Kathleen Maxian is an advanced stage ovarian cancer survivor. Because of the inherited BRCA 1 gene mutation, she was predisposed to breast and ovarian cancer that could have been detected through genetic testing. Those genetic tests are now readily available to American women thanks to a 2013 U.S. Supreme Court decision that declared it illegal for any biotechnology company to hold a patent on a gene. She has been credited in helping that groundbreaking decision happen through her patient advocacy. You can find her on Twitter @KathleenMaxian.